Sherley Amendment

Sherley Amendment (1911)

Legislation passed in the US in 1912 in response to the US Supreme Court’s decision in US v Johnson [221 U.S. 488 (1911)], which ruled that the misbranding provisions of the 1906 Pure Food and Drugs Act only prohibited false statements as to the identity of a drug, but did not pertain to false curative or therapeutic statements. The Amendment addressed the lack of enforcement of fraud related to therapeutic claims intended to defraud the purchaser, a standard which was difficult to prove.
References in periodicals archive ?
One of the most important subsequent changes to the 1906 act was the addition of the Sherley Amendment in response to the ruling of the U.
To reverse the effect of the ruling, Congress enacts the Sherley Amendment prohibiting labeling medicines with false therapeutic claims intended to defraud the purchaser.